Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Memb
Within-sibship genome-wide association analyses decrease bias in estimates of direct genetic effects | Nature Genetics
Agenda - Neurotech Partnering
Agenda - Neurotech Partnering
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents
PDF) Applicability of Cable Theory to Vascular Conducted Responses | Lars Jensen - Academia.edu
JPM | Free Full-Text | Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders
Cu2O/CuS Nanocomposites Show Excellent Selectivity and Stability for Formate Generation via Electrochemical Reduction of Carbon Dioxide | ACS Materials Letters
Thomas Holm Pedersen - Crunchbase Person Profile
NMD Pharma
PDF) Extracellular magnesium and calcium reduce myotonia in C1C-1 inhibited rat muscle
Chloride channel inhibition improves neuromuscular function under conditions mimicking neuromuscular disorders - Pedersen - 2021 - Acta Physiologica - Wiley Online Library
NMD Pharma A/S | LinkedIn
HITTA ER ET A UN AMI TA ON HI HA UT ME AT THE
Agenda - Neurotech Partnering
NMD Pharma Org Chart | The Org
JEITO CAPITAL becomes key investor in NMD Pharma as part of a €35 Million new financing - Jeito
Annual Report 2018 by Lundbeckfonden - Issuu
Chloride channel inhibition improves neuromuscular function under conditions mimicking neuromuscular disorders - Pedersen - 2021 - Acta Physiologica - Wiley Online Library
Convention Speakers - Global CMT Research Convention
Chasing Big Pharma rivals, NMD posts data on rare disease drug
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents
NMD Pharma Org Chart | The Org
NMD Pharma breder sig til nye områder før næste kapitalrejsning
